Showing 1 - 1 results of 1 for search 'Linda D. Bosserman', query time: 0.01s Refine Results
  1. 1
    UGT1A1*28 polymorphism and the risk of toxicity and disease progression in patients with breast cancer receiving sacituzumab govitecan

    UGT1A1*28 polymorphism and the risk of toxicity and disease progression in patients with breast cancer receiving sacituzumab govitecan by Megan H. Wong, Veronica C. Jones, Wai Yu, Linda D. Bosserman, Sayeh M. Lavasani, Niki Patel, Mina S. Sedrak, Daphne B. Stewart, James R. Waisman, Yuan Yuan, Joanne E. Mortimer

    Published 2024-08-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: